Prelude Capital Management, LLC Integra Lifesciences Holdings Corp Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$52.61 - $60.49 $271,678 - $312,370	5,164 New	5,164 $296,000
Q2 2022 Aug 15, 2022	BUY	$53.86 - $66.52 $284,165 - $350,959	5,276 New	5,276 $285,000
Q3 2020 Nov 16, 2020	SELL	$43.33 - $51.72 $779 - $930	-18 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$41.42 - $55.57 $745 - $1,000	18 New	18 $1,000
Q1 2019 May 15, 2019	SELL	$42.97 - $57.33 $6,402 - $8,542	-149 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$42.62 - $64.51 $6,350 - $9,611	149 New	149 $7,000

241

75.3M

585K

21.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.